Vetrano, E.; Galiero, R.; Simeon, V.; Palmiero, G.; Cesaro, A.; Caturano, A.; Rinaldi, L.; Salvatore, T.; Ruggiero, R.; Di Palo, M.R.;
et al. Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study. Pharmaceuticals 2025, 18, 1200.
https://doi.org/10.3390/ph18081200
AMA Style
Vetrano E, Galiero R, Simeon V, Palmiero G, Cesaro A, Caturano A, Rinaldi L, Salvatore T, Ruggiero R, Di Palo MR,
et al. Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study. Pharmaceuticals. 2025; 18(8):1200.
https://doi.org/10.3390/ph18081200
Chicago/Turabian Style
Vetrano, Erica, Raffaele Galiero, Vittorio Simeon, Giuseppe Palmiero, Arturo Cesaro, Alfredo Caturano, Luca Rinaldi, Teresa Salvatore, Roberto Ruggiero, Maria Rosaria Di Palo,
and et al. 2025. "Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study" Pharmaceuticals 18, no. 8: 1200.
https://doi.org/10.3390/ph18081200
APA Style
Vetrano, E., Galiero, R., Simeon, V., Palmiero, G., Cesaro, A., Caturano, A., Rinaldi, L., Salvatore, T., Ruggiero, R., Di Palo, M. R., Sardu, C., Marfella, R., Calabrò, P., & Sasso, F. C.
(2025). Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study. Pharmaceuticals, 18(8), 1200.
https://doi.org/10.3390/ph18081200